What should you know about rhabdomyosarcoma immunohistochemistry pathology outlines?

A biopsy removes a small tissue sample for examination. In immunohistochemistry, laboratory antibodies attach to selected proteins in the cells and create a visible staining pattern. The pathologist interprets that pattern with the cell shape, tumour location, age and other pathology findings. A stain is not a diagnosis by itself: some proteins occur in more than one tumour, and a panel of stains may be needed to separate rhabdomyosarcoma from other small round-cell tumours.

Ask whether the sample is adequate, whether the diagnosis has been reviewed by a specialist sarcoma pathologist, and whether molecular testing is needed. Keep a copy of the pathology report and ask the team to explain unfamiliar terms such as positive, negative, focal or diffuse staining. Treatment decisions should use the complete diagnosis and staging information, not an isolated stain result. Read more about Immunohistochemistry and Biopsy.

After a biopsy, contact the treating team for increasing redness, swelling, drainage, fever, worsening pain or bleeding at the sample site. Seek urgent help for heavy bleeding, fainting, breathing difficulty, or sudden severe pain. A pathology result may take time when additional stains or expert review are required; ask the team when and how results will be communicated.

Ask which markers were tested, what each result contributes, and whether the findings support rhabdomyosarcoma or another tumour. Ask if the tissue will be reviewed by a sarcoma specialist, whether molecular tests are planned, and how the final report will guide staging and treatment.